Potentiating action of 5-fluorouracil when used in combination with platinium compounds and cyclophosphamide in treatment of advanced L1210 leukemia
- PMID: 687671
- DOI: 10.1016/s0006-3061(00)80279-3
Potentiating action of 5-fluorouracil when used in combination with platinium compounds and cyclophosphamide in treatment of advanced L1210 leukemia
Abstract
Nine new organoplatinum (Pt) compounds, cyclophosphamide (CY), and 5-fluorouracil (FU) were used singly and in combination in treatment of advanced L1210 leukemia in C57BL/6 X DBA/2 hybrid mice. In each experiment the Pt + CY dual combination was minimally supra-additive at the doses chosen. However, eight of the nine Pt + CY + FU combination regimens enhanced markedly the increased life span of treated mice as compared with the corresponding dual Pt + CY combination. Collectively, the cure rate (greater than 60-day survival) was less than 6% with the various Pt + CY combinations, and was increased to over 63% upon inclusion of FU in the regimens.
Similar articles
-
Synergistic action of high-dose hydroxyurea when used with cyclophosphamide and certain new organoplatinum complexes in treatment of advanced L1210 leukemia.Cancer. 1978 Apr;41(4):1230-4. doi: 10.1002/1097-0142(197804)41:4<1230::aid-cncr2820410402>3.0.co;2-q. Cancer. 1978. PMID: 638988
-
Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.J Natl Cancer Inst. 1976 Dec;57(6):1363-6. doi: 10.1093/jnci/57.6.1363. J Natl Cancer Inst. 1976. PMID: 187805
-
Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.Cancer Treat Rep. 1977 May-Jun;61(3):445-50. Cancer Treat Rep. 1977. PMID: 872142
-
Schedule-dependency assessments of ribonucleoside diphosphate reductase inhibitors when used in combination with platinum compounds plus cyclophosphamide in the treatment of advanced L1210 leukemia.Cancer Treat Rep. 1979 Mar;63(3):449-56. Cancer Treat Rep. 1979. PMID: 427825
-
Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.Cancer Treat Rep. 1987 Jul-Aug;71(7-8):727-32. Cancer Treat Rep. 1987. PMID: 3607784
Cited by
-
Cyclophosphamide and cis-dichlorodiammine platinum (11). Nonempiric scheduling to spare dose-limiting tissues in the rat.Cancer Chemother Pharmacol. 1980;4(2):103-9. doi: 10.1007/BF00254030. Cancer Chemother Pharmacol. 1980. PMID: 7190083 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources